December 2023 - Cancer Currents Blog
-
New on NCI’s Websites for December 2023NCI periodically provides updates on new websites and other online content of interest to the cancer community. See selected content that has been added as of December 2023.
-
Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-UpIn a clinical trial, a simple letter and phone call helped increase the number of people who completed the recommended follow-up testing after an abnormal cancer screening result.
-
Genetic Signature May Help Tailor Treatment for MeningiomaThe activity of 34 genes can accurately predict the aggressiveness of meningiomas, a new study shows. This gene expression signature may help oncologists select the best treatments for people with this common type of brain cancer than they can with current methods.
-
Virtual Mind–Body Fitness Classes Show Unexpected Benefit in People with CancerIn a clinical trial, people being treated for cancer who participated in virtual mind–body fitness classes were less likely to be hospitalized, and had shorter stays when they were hospitalized, than people who did not take the classes.
-
Antibody Drug Ejects Problematic Proteins from Cancer CellsAntibodies currently used in many cancer treatments have only been able to reach proteins outside of cancer cells. In a new study in mice, scientists found a way to target cancer-fueling KRAS and IDH1 proteins buried inside cancer cells.
-
What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer TrialsNCI’s James H. Doroshow, M.D., reflects on the accomplishments of NCI-MATCH, a first-of-its-kind precision medicine cancer trial, and gives an overview of three new successor trials: ComboMATCH, MyeloMATCH, and iMATCH.
-
Tarlatamab Shows Promise for Some People with Small Cell Lung CancerTarlatamab, a new type of targeted immunotherapy, shrank small cell lung cancer (SCLC) tumors in more than 30% of participants in an early-stage clinical trial. Participants had SCLC that had progressed after previous treatments with other drugs.